|
|
||||||||
Gene: The TATA-Less CD3
Promoter Functions via an Initiator and Contiguous Sp-Binding Elements 1



* Laboratory of Experimental Hematology, Bordet Institute, Faculty of Medicine, University of Brussels, Brussels, Belgium; and
Division of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611
Growing evidence that the CD3
gene is specifically targeted in some T cell diseases focused our attention on the need to identify and characterize the elusive elements involved in CD3
transcriptional control. In this study, we show that while the human CD3
and CD3
genes are oriented head-to-head and separated by only 1.6 kb, the CD3
gene is transcribed from an independent but weak, lymphoid-specific TATA-less proximal promoter. Using RNA ligase-mediated rapid amplification of cDNA ends, we demonstrate that a cluster of transcription initiation sites is present in the vicinity of the primary core promoter, and the major start site is situated in a classical initiator sequence. A GT box immediately upstream of the initiator binds Sp family proteins and the general transcription machinery, with the activity of these adjacent elements enhanced by the presence of a second GC box 10 nt further upstream. The primary core promoter is limited to a sequence that extends upstream to 15 and contains the initiator and GT box. An identical GT box located
50 nt from the initiator functions as a weak secondary core promoter and likely generates transcripts originating upstream from the +1. Finally, we show that two previously identified NFAT motifs in the proximal promoter positively (NFAT
1) or negatively (NFAT
1 and NFAT
2) regulate expression of the human CD3
gene by their differential binding of NFATc1 plus NF-
B p50 or NFATc2 containing complexes, respectively. These data elucidate some of the mechanisms controlling expression of the CD3
gene as a step toward furthering our understanding of how its transcription is targeted in human disease.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |